JP2022504298A5 - - Google Patents

Info

Publication number
JP2022504298A5
JP2022504298A5 JP2021518664A JP2021518664A JP2022504298A5 JP 2022504298 A5 JP2022504298 A5 JP 2022504298A5 JP 2021518664 A JP2021518664 A JP 2021518664A JP 2021518664 A JP2021518664 A JP 2021518664A JP 2022504298 A5 JP2022504298 A5 JP 2022504298A5
Authority
JP
Japan
Prior art keywords
chloro
oxo
chromen
phenoxy
acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
JP2021518664A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022504298A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2019/076502 external-priority patent/WO2020070088A1/en
Publication of JP2022504298A publication Critical patent/JP2022504298A/ja
Publication of JP2022504298A5 publication Critical patent/JP2022504298A5/ja
Ceased legal-status Critical Current

Links

JP2021518664A 2018-10-03 2019-10-01 B型肝炎ウイルス疾患の処置および予防のためのフラボン誘導体 Ceased JP2022504298A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CNPCT/CN2018/109241 2018-10-03
CN2018109241 2018-10-03
PCT/EP2019/076502 WO2020070088A1 (en) 2018-10-03 2019-10-01 Flavone derivatives for the treatment and prophylaxis of hepatitis b virus disease

Publications (2)

Publication Number Publication Date
JP2022504298A JP2022504298A (ja) 2022-01-13
JP2022504298A5 true JP2022504298A5 (https=) 2024-03-04

Family

ID=68172177

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021518664A Ceased JP2022504298A (ja) 2018-10-03 2019-10-01 B型肝炎ウイルス疾患の処置および予防のためのフラボン誘導体

Country Status (5)

Country Link
US (1) US11708344B2 (https=)
EP (1) EP3860984A1 (https=)
JP (1) JP2022504298A (https=)
CN (1) CN112912371A (https=)
WO (1) WO2020070088A1 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2020052774A1 (en) * 2018-09-14 2020-03-19 F. Hoffmann-La Roche Ag Flavone derivatives for the treatment and prophylaxis of hepatitis b virus disease
JP2022514470A (ja) * 2018-12-14 2022-02-14 エフ.ホフマン-ラ ロシュ アーゲー B型肝炎ウイルス感染症を治療および予防するためのクロマン-4-オン誘導体
WO2020120528A1 (en) * 2018-12-14 2020-06-18 F. Hoffmann-La Roche Ag N-containing chromen-4-one derivatives for the treatment and prophylaxis of hepatitis b virus infection
CN116947799B (zh) * 2023-03-08 2024-05-03 上海泽德曼医药科技有限公司 酚类化合物、其制备方法及其在医药上的应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6555523B1 (en) * 1999-07-08 2003-04-29 Patrick T. Prendergast Use of cirsiliol and derivatives to treat infections
GB0216371D0 (en) 2002-07-13 2002-08-21 Rowett Res Inst The Compounds
CN100415731C (zh) 2004-12-30 2008-09-03 财团法人工业技术研究院 治疗b型肝炎的化合物及其医药组合物
AU2007252947B2 (en) 2006-05-19 2011-12-01 Mcgill University Flavonoid dimers and methods of making and using such
WO2013127361A1 (en) 2012-03-01 2013-09-06 The Hong Kong Polytechnic University Alkyne-, azide- and triazole-containing flavonoids as modulators for multidrug resistance in cancers
WO2014074976A1 (en) 2012-11-09 2014-05-15 Musc Foundation For Research Development Compositions and methods for treating neurological diseases or injury
CA2927009C (en) 2013-10-21 2019-04-23 Drexel University Use of sting agonists to treat chronic hepatitis b virus infection
US9868715B2 (en) 2014-04-19 2018-01-16 The Board Of Regents Of The University Of Texas Systems Apigenin analogs, compositions, and methods related thereto
CN112888480A (zh) 2018-10-24 2021-06-01 豪夫迈·罗氏有限公司 用于治疗和预防乙型肝炎病毒疾病的新型三环化合物

Similar Documents

Publication Publication Date Title
JP2022504298A5 (https=)
KR101204336B1 (ko) Cetp 억제제
CN1095839C (zh) 4,5-二芳基噁唑衍生物
CN1072222C (zh) 以c-c键连接于4-8元杂环环的苯基噁唑烷酮
JP5119924B2 (ja) 含窒素複素環化合物およびその医薬用途
RU2383524C2 (ru) Гексафторизопропанол-замещенные производные простых эфиров
JP2019077725A5 (https=)
CN1170827C (zh) 苯并呋喃基吡喃酮衍生物
JP2010508338A5 (https=)
JP2022546029A5 (https=)
CN1426405A (zh) 新型环状酰胺衍生物
RU2009102770A (ru) Производные бензимидазола, методы их получения, применение их в качестве агонистов фарнезоид-х-рецептора (fxr) и содержащие их фармацевтические препараты
JP2004534824A5 (https=)
JP2005538955A5 (https=)
CN1578659A (zh) 过氧化物酶体增殖剂激活的受体(ppar)的调节剂
RU2006142746A (ru) Индолилпроизводные в качестве модуляторов печеночного х-рецептора
JP2007511485A5 (https=)
JP2005508308A5 (https=)
JP2022544248A5 (https=)
JP2022538774A5 (https=)
JPWO2010001946A1 (ja) トリアゾール誘導体またはその塩
JP2009504792A5 (https=)
JP2017525697A5 (https=)
JP2009256208A (ja) フタリド誘導体またはその薬学的に許容される塩
JP2010509216A (ja) ヘテロシクリル置換抗高コレステロール血症化合物